Citi analyst, Stephanie Demko, reiterated her Buy rating on shares of Allscripts (NASDAQ: MDRX) on the belief that there is ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE